ArticleFrontiers in public health2026
Population burden of diabetes, hypertension, and cardiovascular disease attributable to obesity: a community-based study in Türkiye.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity has emerged as a global public health pandemic, with rapidly increasing prevalence and a growing burden of obesity-related chronic diseases worldwide. Despite its high prevalence, obesity remains underdiagnosed, limiting effective prevention and management. Reliable, region-specific epidemiological data are therefore essential to guide public health interventions and policy development. This study aimed to examine the prevalence of obesity and its associations with chronic diseases across different age and sex groups in the community. Methods: The study included adults residing in Amasya, northern Türkiye. Data were collected at field booths between 15 June and 31 July 2025. Height and weight were measured using standardized procedures, while chronic diseases were self-reported. Associations of obesity with diabetes, hypertension, and cardiovascular disease were assessed using age- and sex-adjusted logistic regression, including interaction analyses. Attributable measures were also calculated. Results: The study included 22,667 adults (50.6% women), with a mean age of 46.4 ± 16.1 years. The prevalence of obesity was 29.9% and was higher among women than men (35.7% vs. 23.9%). The prevalences of diabetes mellitus, hypertension, and cardiovascular disease were 12.1, 16.2, and 6.6%, respectively, and were substantially higher among individuals with obesity than among those without obesity. After adjustment for age and sex, obesity was associated with higher odds of diabetes mellitus [adjusted odds ratio (aOR) = 2.88, 95% CI 2.65-3.14], hypertension (aOR = 2.50, 95% CI 2.31-2.70), and cardiovascular disease (aOR = 2.29, 95% CI 2.05-2.56). The adjusted population attributable fractions of obesity were 31.5% for diabetes mellitus, 25.8% for hypertension, and 26.1% for cardiovascular disease. Age significantly modified the associations between obesity and all three chronic conditions, whereas no significant interaction with sex was observed. Conclusion: This community-based study demonstrates that obesity is highly prevalent and strongly associated with DM, HT, and CVD. The substantial population-level burden of these conditions statistically attributable to obesity further underscores its importance as a major public health problem. These findings support strengthening evidence-based strategies that promote healthy weight through lifestyle modification and population-based prevention approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.